Our CEO and Founder, Professor Sir Peter Donnelly, was interviewed on BBC News regarding the UK Government's plans for investment in the Oxford and Cambridge region.

Our research shows very high risk individuals reached the risk levels associated with usual starting screening ages 12.4 years earlier, on average. In other words, if a screening programme were devised on the basis of the average risk facing a 50-year-old, this high risk group would have the same predicted risk at the age of 37.6. Recommendations for earlier screening for genetically very high risk groups ranged from four years in advance for abdominal aortic aneurysm, to 22 years for hypertension.

Our research shows that those at high genetic risk of obesity will need personalised support to help them stay at, or return to, a healthy weight.

Genomics releases new research showing significant link between genetic risk and obesity

Genomics announces the appointment of David Thornton to the position of President, succeeding Professor Gil McVean, who will join the board as a non-executive Director.

Research by Genomics plc has identified that 8% of the adult population have the same risk of heart disease due to polygenic risk, as carriers of rare genetic mutations that cause familial hypercholesterolemia (FH).

The three-year extension expands the range of therapeutic areas and genomic data insights and also explores the use of genomic risk to better define patient subgroups

The collaboration, across multiple therapeutic areas, will evaluate how polygenic risk scores could be used to improve clinical trial design and efficiency

The wellness offering utilizes advanced genetics to provide personalized risk information for common and preventable diseases, including heart disease, diabetes, breast and prostate cancer